Logo image of USAR

USA RARE EARTH INC (USAR) Stock Fundamental Analysis

NASDAQ:USAR - Nasdaq - US91733P1075 - Common Stock - Currency: USD

10.71  -0.29 (-2.64%)

After market: 10.84 +0.13 (+1.21%)

Fundamental Rating

2

Taking everything into account, USAR scores 2 out of 10 in our fundamental rating. USAR was compared to 154 industry peers in the Metals & Mining industry. The financial health of USAR is average, but there are quite some concerns on its profitability. USAR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

USAR had positive earnings in the past year.
USAR had a negative operating cash flow in the past year.
USAR Yearly Net Income VS EBIT VS OCF VS FCFUSAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of 59.96%, USAR belongs to the top of the industry, outperforming 98.71% of the companies in the same industry.
Industry RankSector Rank
ROA 59.96%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USAR Yearly ROA, ROE, ROICUSAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for USAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USAR Yearly Profit, Operating, Gross MarginsUSAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

USAR has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for USAR is higher compared to a year ago.
USAR Yearly Shares OutstandingUSAR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M
USAR Yearly Total Debt VS Total AssetsUSAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

USAR has an Altman-Z score of 4.97. This indicates that USAR is financially healthy and has little risk of bankruptcy at the moment.
USAR has a Altman-Z score of 4.97. This is in the better half of the industry: USAR outperforms 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 4.97
ROIC/WACCN/A
WACCN/A
USAR Yearly LT Debt VS Equity VS FCFUSAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

USAR has a Current Ratio of 3.52. This indicates that USAR is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.52, USAR is doing good in the industry, outperforming 72.90% of the companies in the same industry.
USAR has a Quick Ratio of 3.52. This indicates that USAR is financially healthy and has no problem in meeting its short term obligations.
USAR's Quick ratio of 3.52 is fine compared to the rest of the industry. USAR outperforms 76.13% of its industry peers.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 3.52
USAR Yearly Current Assets VS Current LiabilitesUSAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.97% over the past year.
EPS 1Y (TTM)101.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%567.99%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, USAR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.53% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y96.46%
EPS Next 2Y-33.4%
EPS Next 3Y19.53%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
USAR Yearly Revenue VS EstimatesUSAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 50M 100M 150M
USAR Yearly EPS VS EstimatesUSAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.1 -0.2 -0.3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.27, which indicates a rather expensive current valuation of USAR.
Based on the Price/Earnings ratio, USAR is valued cheaply inside the industry as 80.65% of the companies are valued more expensively.
USAR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
The Forward Price/Earnings Ratio is negative for USAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 17.27
Fwd PE N/A
USAR Price Earnings VS Forward Price EarningsUSAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAR Per share dataUSAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

USAR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as USAR's earnings are expected to grow with 19.53% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y-33.4%
EPS Next 3Y19.53%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for USAR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

USA RARE EARTH INC

NASDAQ:USAR (7/11/2025, 8:00:02 PM)

After market: 10.84 +0.13 (+1.21%)

10.71

-0.29 (-2.64%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)06-23 2025-06-23/bmo
Earnings (Next)N/A N/A
Inst Owners16.85%
Inst Owner Change0%
Ins Owners13.52%
Ins Owner Change1.74%
Market Cap1.01B
Analysts82.22
Price Target17.68 (65.08%)
Short Float %2.89%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.56%
PT rev (3m)15.56%
EPS NQ rev (1m)-14.81%
EPS NQ rev (3m)-72.22%
EPS NY rev (1m)96.82%
EPS NY rev (3m)96.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.27
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.62
EY5.79%
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0
BVpS-0.24
TBVpS-0.24
PEG (NY)0.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 59.96%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.52
Quick Ratio 3.52
Altman-Z 4.97
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1089.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%567.99%
EPS Next Y96.46%
EPS Next 2Y-33.4%
EPS Next 3Y19.53%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1098.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.76%
OCF growth 3YN/A
OCF growth 5YN/A